BioPharma Dive 5 ene 2026 Zenas shares crash after top drug misses expectations in immune disease study
BioPharma Dive 5 ene 2026 Strategic diagnostic testing partnerships are accelerating clinical research
BioPharma Dive 22 dic 2025 Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
BioPharma Dive 22 dic 2025 Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug